Page 204 - Genentech News Today

(RTTNews) - Genentechs vabysmo rapidly improved vision and reduced retinal fluid in people with retinal vein occlusion or RVO, as per new data fr...

Vabysmo met its primary endpoint in two clinical trials, BALATON and COMINO, showing non-inferior visual acuity gains compared to afliberceptMore Vabysmo patients showed an absence of blood vessel leakage

Two Big Pharma companies have announced management changes in 2023: Astellas will have a new President and CEO and Bayer AG, a new CEO.

The Nobel Prize in Chemistry 2018 was divided, one half awarded to Frances H. Arnold "for the directed evolution of enzymes", the other half jointly to George P. Smith and Sir Gregory P. Winter "for the phage display of peptides and antibodies"

Island Pharmaceuticals Ltd (ASX:ILA) CEO and managing director David Foster believes in the vital role of the biotech industry in harnessing science to...

/PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has expanded its collaboration with Janssen Biotech Inc. (Janssen) to create...

/PRNewswire/ -- Today the Edison Awards is proud to announce its 2023 finalists, honoring excellence in new product and service development, marketing,...

Reports Full-Year Diluted EPS of $6.63 on a GAAP Basis, an Increase of 2.8 Percent; Adjusted Diluted EPS of $13.77, an Increase of 16.4 Percent; These Results...

Although the breakthrough infection rate has been high in patients using rituximab during the later stages of the COVID-19 pandemic, a small proportion of those who are fully vaccinated develop severe outcomes, according to data.

The Supervisory Board of Bayer AG has appointed Bill Anderson to become CEO of Bayer, effective June 1, 2023. He will join Bayer as a member of the Board of Management on April 1, 2023. Bill Ander ...